ALNYLAM PHARMACEUTICALS INC

ALNYNASDAQ

🏆 #386 by market capEarnings Oct 29 · Pre🧬Biotech

$232.50▲ $5.78 (+2.55%)

Market closed · at close

Get earnings, price moves & breaking news on Telegram

24h▲ 2.5%

7d▲ 2.3%

14d▼ 0.6%

30d▼ 8.5%

ytd▼ 41.5%

1y▼ 51.8%

🏦Market Cap

$31.11B

Mid Cap

📈Revenue Growth (YoY)

65.2%

High Growth

📊Gross Margin

79.7%

High

💵FCF Margin

11.3%

Healthy

⚖️P/S Ratio

6.5x

Fair

Otter Score

72

Strong

Earnings

Q2 · 2026Reported 2026-06-30

Earnings Per Share

Actual

1.21

Expected

1.59

miss

−23.70%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q2 2026

1.21

miss

Q1 2026

1.51

beat

Q4 2025

0.82

miss

Q3 2025

2.11

beat